DNB Aktiv 80 A vs UBS Lux Equity Fund Biotech USD
1. DNB Aktiv 80 A
-
Security
DNB Aktiv 80 A
-
Fee
1.04%
-
ISIN
NO0010337793
-
Holdings
3
2. UBS Lux Equity Fund Biotech USD
Fund Holdings
We have information about 3 holdings in DNB Aktiv 80 A, where the largest holding is Proethos Fond (19.72), followed by Alfred Berg Optimal D (5.4) and Nordnet One Offensiv (2.9). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).
All Holdings
Here we compare the holdings in DNB Aktiv 80 A and UBS Lux Equity Fund Biotech USD.
DNB Aktiv 80 A |
UBS Lux Equity Fund Biotech USD |
1. Proethos Fond  19.72 % |
1. Regeneron Pharmaceuticals Inc 10.04 % |
2. Alfred Berg Optimal D 5.4 % |
2. Vertex Pharmaceuticals Inc 9.9 % |
3. Nordnet One Offensiv NOK  2.9 % |
3. Moderna Inc 9.21 % |
- |
4. Alnylam Pharmaceuticals Inc 6.54 % |
- |
5. AbbVie Inc  5.52 % |
- |
6. Gilead Sciences Inc  4.66 % |
- |
7. Amgen Inc 4.32 % |
- |
8. BioNTech SE 4.13 % |
- |
9. Karuna Therapeutics Inc 3.75 % |
- |
10. Royalty Pharma Plc 3.28 % |
The list of fund holdings was last updated on April 17, 2025.